News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
880,169 Results
Type
Article (88592)
Company Profile (815)
Press Release (790728)
Multimedia
Podcasts (228)
Webinars (34)
Section
Business (233514)
Career Advice (4158)
Deals (39950)
Drug Delivery (172)
Drug Development (91616)
Employer Resources (207)
FDA (18518)
Job Trends (17472)
News (398532)
Policy (40012)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (3043)
Academic (2)
Accelerated approval (48)
Adcomms (39)
Allergies (184)
Alliances (56987)
ALS (222)
Alzheimer's disease (1927)
Antibody-drug conjugate (ADC) (491)
Approvals (18799)
Artificial intelligence (804)
Autoimmune disease (304)
Automation (59)
Bankruptcy (407)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (237)
Biotechnology (486)
Bladder cancer (196)
Brain cancer (80)
Breast cancer (791)
Cancer (6126)
Cardiovascular disease (522)
Career advice (3590)
Career pathing (48)
CAR-T (354)
CDC (75)
Celiac Disease (3)
Cell therapy (989)
Cervical cancer (48)
Clinical research (78372)
Collaboration (2239)
Company closure (8)
Compensation (1417)
Complete response letters (100)
COVID-19 (3028)
CRISPR (119)
C-suite (1181)
Cystic fibrosis (162)
Data (7921)
Decentralized trials (3)
Denatured (86)
Depression (185)
Dermatology (85)
Diabetes (630)
Diagnostics (7500)
Digital health (60)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (393)
Drug pricing (244)
Drug shortages (39)
Duchenne muscular dystrophy (302)
Earnings (102090)
Editorial (77)
Employer branding (25)
Employer resources (174)
Events (137446)
Executive appointments (1155)
FDA (22359)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (35)
Funding (1839)
Gene editing (259)
Generative AI (85)
Gene therapy (809)
GLP-1 (1243)
Government (5539)
Grass and pollen (8)
Guidances (412)
Healthcare (21084)
HIV (89)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (101)
Immunology and inflammation (344)
Immuno-oncology (100)
Indications (181)
Infectious disease (3401)
Inflammatory bowel disease (239)
Inflation Reduction Act (17)
Influenza (147)
Intellectual property (299)
Interviews (820)
IPO (17990)
IRA (61)
Job creations (5205)
Job search strategy (2870)
JPM (73)
Kidney cancer (22)
Labor market (111)
Layoffs (678)
Leadership (49)
Legal (10171)
Liver cancer (107)
Longevity (35)
Lung cancer (803)
Lymphoma (435)
Machine learning (63)
Management (66)
Manufacturing (1125)
MASH (202)
Medical device (15221)
Medtech (15337)
Mergers & acquisitions (23211)
Metabolic disorders (1678)
mRNA (242)
Multiple sclerosis (196)
NASH (24)
Neurodegenerative disease (464)
Neuropsychiatric disorders (124)
Neuroscience (3564)
Neurotech (2)
NextGen: Class of 2026 (7713)
Non-profit (5137)
Now hiring (78)
Obesity (815)
Opinion (366)
Ovarian cancer (222)
Pain (272)
Pancreatic cancer (309)
Parkinson's disease (384)
Partnered (39)
Patents (623)
Patient recruitment (693)
Peanut (67)
People (67718)
Pharmaceutical (138)
Pharmacy benefit managers (36)
Phase 1 (24211)
Phase 2 (34044)
Phase 3 (25607)
Pipeline (8533)
Policy (383)
Postmarket research (3558)
Preclinical (10896)
Press Release (72)
Prostate cancer (310)
Psychedelics (68)
Radiopharmaceuticals (351)
Rare diseases (1182)
Real estate (7457)
Recruiting (81)
Regulatory (30049)
Reports (77)
Research institute (2763)
Resumes & cover letters (653)
Rett syndrome (37)
RNA editing (26)
RSV (98)
Schizophrenia (191)
Series A (312)
Series B (224)
Service/supplier (30)
Sickle cell disease (120)
Special edition (31)
Spinal muscular atrophy (188)
Sponsored (54)
Startups (4362)
State (2)
Stomach cancer (21)
Supply chain (139)
Tariffs (104)
The Weekly (139)
Vaccines (1263)
Venture capital (122)
Weight loss (561)
Women's health (129)
Worklife (24)
Date
Today (243)
Last 7 days (1006)
Last 30 days (3558)
Last 365 days (33180)
2026 (12518)
2025 (33226)
2024 (38124)
2023 (42564)
2022 (53928)
2021 (58721)
2020 (57664)
2019 (51336)
2018 (39119)
2017 (37189)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1296)
Alabama (100)
Alaska (7)
Arizona (387)
Arkansas (16)
Asia (52058)
Australia (9156)
California (13605)
Canada (3829)
China (1430)
Colorado (588)
Connecticut (602)
Delaware (417)
Europe (120018)
Florida (2017)
Georgia (443)
Hawaii (4)
Idaho (69)
Illinois (1166)
India (97)
Indiana (634)
Iowa (25)
Japan (543)
Kansas (139)
Kentucky (56)
Louisiana (46)
Maine (88)
Maryland (1667)
Massachusetts (9942)
Michigan (409)
Minnesota (759)
Mississippi (7)
Missouri (160)
Montana (37)
Nebraska (30)
Nevada (147)
New Hampshire (92)
New Jersey (3630)
New Mexico (34)
New York (3573)
North Carolina (1845)
North Dakota (10)
Northern California (6699)
Ohio (421)
Oklahoma (26)
Oregon (55)
Pennsylvania (2707)
Puerto Rico (30)
Rhode Island (53)
South America (1668)
South Carolina (87)
South Dakota (2)
Southern California (5323)
Tennessee (216)
Texas (2198)
United States (48792)
Utah (408)
Vermont (1)
Virginia (349)
Washington D.C. (88)
Washington State (1125)
West Virginia (4)
Wisconsin (152)
Wyoming (2)
There are 880,169 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Alzheimer’s disease
Biogen, Eisai hit with 3-month delay for starting SubQ Alzheimer’s therapy
The FDA’s extension will give reviewers more time to review a major amendment to Biogen and Eisai’s application for a subcutaneous induction formulation of Alzheimer’s therapy Leqembi. The new target action date is on Aug. 24.
May 8, 2026
·
2 min read
·
Tristan Manalac
Manufacturing
Lilly invests $4.5B in Indiana manufacturing, opens doors of 1st genetic medicine site
Eli Lilly’s latest manufacturing expansion will support production of obesity blockbusters and next-gen assets, while the new Lilly Lebanon Advanced Therapies site will take experimental genetic medicines from research to commercialization.
May 8, 2026
·
1 min read
·
Gabrielle Masson
IPO tracker
Odyssey launches upsized $279M IPO, Seaport docks on Nasdaq
Analysts are cautiously optimistic about an IPO rebound for biopharma.
BioSpace
is keeping track of companies that seek to trade on the public markets this year.
May 8, 2026
·
12 min read
·
Editorial Team
Press Releases
Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference
May 8, 2026
·
1 min read
Press Releases
Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib) for the Treatment of Active Psoriatic Arthritis in Adults
May 8, 2026
·
18 min read
Press Releases
Tvardi Therapeutics Announces First Quarter 2026 Results and Provides Business Update
May 8, 2026
·
8 min read
Press Releases
MapLight Therapeutics to Participate in Upcoming Investor Conferences - May 8, 2026
May 8, 2026
·
1 min read
Press Releases
Boundless Bio Reports First Quarter 2026 Financial Results and Business Highlights
May 8, 2026
·
8 min read
Press Releases
Regeneron Named to Dow Jones Best-in-Class World Index for Global Responsibility Leadership for Seven Consecutive Years
May 8, 2026
·
5 min read
Press Releases
LENSAR® Reports First Quarter 2026 Results and Provides Business Update
May 8, 2026
·
14 min read
1 of 88,017
Next
